MedPath

Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation

Not Applicable
Completed
Conditions
Hypercholesterolemia
Interventions
Combination Product: Cardio-complement
Registration Number
NCT04974853
Lead Sponsor
NMP Medical Research Institute
Brief Summary

The aim of this feasibility study was to assess the lipid-lowering effects and safety of a Ayurveda formulation containing Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer)

Detailed Description

The COVID-19 related lockdowns severely affected the healthcare in India, specially in second wave of COVID-19. This research presents the applicability of Ayurveda formulation to analyze the impact on lipid profile during the lockdown.

Patients with hyperlipidemia who referred to Gyansanjeevani were recruited. All participants were enrolled in the study after a complete physical examination and medical history remotely over the virtual secure platform.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Age between 18 and 65 years
  • BMI between 18.5 and 40 kg/m2
  • Total Cholesterol >180 mg/dl
  • No clinically significant medical history
  • Willing to participate to the study by complying with the protocol
  • Able to provide written informed consent
Exclusion Criteria
  • Metabolic disorder such as diabetes, uncontrolled thyroidal trouble or other metabolic disorder,
  • Severe chronic disease
  • History of ischemic cardiovascular event,
  • Uncontrolled hypertension
  • Under treatment or dietary supplement which could affect study parameter

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Ayurveda FormulationCardio-complementPatients with hypercholesterolemia treated with Ayurveda formulation, Cardio-Complement
Primary Outcome Measures
NameTimeMethod
Reduction of LDL-cholesterolChange from baseline to 2 weeks
Secondary Outcome Measures
NameTimeMethod
Reduction of total cholesterolChanges from baseline to 2 weeks
Reduction of TriglyceridesChange from baseline to 2 weeks
Increase of HDL cholesterolChange from baseline to 2 weeks

Trial Locations

Locations (1)

Gyansanjeevani

🇮🇳

Jaipur, Rajasthan, India

© Copyright 2025. All Rights Reserved by MedPath